Variant report
Variant | nsv557747 |
---|---|
Chromosome Location | chr12:21815529-21816447 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MAX | chr12:21815247-21815871 | A549 | lung: | n/a | n/a |
2 | POLR2A | chr12:21815658-21815669 | A549 | lung: | n/a | n/a |
3 | POLR2A | chr12:21815143-21815606 | A549 | lung: | n/a | n/a |
4 | POLR2A | chr12:21815126-21815604 | A549 | lung: | n/a | n/a |
5 | POLR2A | chr12:21815642-21815657 | A549 | lung: | n/a | n/a |
6 | RAD21 | chr12:21815551-21815727 | A549 | lung: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:21815512-21815562 | GM12891 | blood: | n/a |
2 | chr12:21815512-21815562 | Hepatocyte | liver: | n/a |
3 | chr12:21815512-21815562 | AG04450 | lung: | fetal |
4 | chr12:21815512-21815562 | HEEpiC | esophagus: | n/a |
5 | chr12:21815512-21815562 | ovcar-3 | ovarian: | n/a |
6 | chr12:21815512-21815562 | HAEpiC | amniotic membrane: | n/a |
7 | chr12:21815512-21815562 | NH-A | brain: | n/a |
8 | chr12:21815512-21815562 | IMR90 | lung: | fetal |
9 | chr12:21815512-21815562 | PFSK-1 | brain: | n/a |
10 | chr12:21815512-21815562 | Jurkat | blood: | n/a |
11 | chr12:21815512-21815562 | NT2-D1 | testis: | n/a |
12 | chr12:21815512-21815562 | PrEC | prostate: | n/a |
13 | chr12:21815512-21815562 | CMK | blood: | n/a |
14 | chr12:21815512-21815562 | AG09319 | gingival: | n/a |
15 | chr12:21815512-21815562 | U87 | brain: | n/a |
16 | chr12:21815512-21815562 | AG10803 | skin: | n/a |
17 | chr12:21815512-21815562 | HCF | heart: | n/a |
18 | chr12:21815512-21815562 | NHBE | bronchial: | n/a |
19 | chr12:21815512-21815562 | Caco-2 | colon: | n/a |
20 | chr12:21815512-21815562 | H1-hESC | embryonic stem cell: | embryo |
21 | chr12:21815512-21815562 | AG09309 | skin: | n/a |
22 | chr12:21815512-21815562 | HUVEC | blood vessel: | n/a |
23 | chr12:21815512-21815562 | HMEC | breast: | n/a |
24 | chr12:21815512-21815562 | HCM | heart: | n/a |
25 | chr12:21815512-21815562 | HRPEpiC | eye: | n/a |
26 | chr12:21815512-21815562 | AoSMC | blood vessel: | n/a |
27 | chr12:21815512-21815562 | NHDF-neo | bronchial: | n/a |
28 | chr12:21815512-21815562 | SKMC | muscle: | n/a |
29 | chr12:21815512-21815562 | T-47D | breast: | n/a |
30 | chr12:21815512-21815562 | ProgFib | skin: | n/a |
31 | chr12:21815512-21815562 | SK-N-MC | brain: | n/a |
32 | chr12:21815512-21815562 | GM12892 | blood: | n/a |
33 | chr12:21815512-21815562 | SK-N-SH | brain: | n/a |
34 | chr12:21815512-21815562 | BE2_C | brain: | n/a |
35 | chr12:21815512-21815562 | HEK293 | kidney: | embryo |
36 | chr12:21815512-21815562 | A549 | lung: | n/a |
37 | chr12:21815512-21815562 | HCT-116 | colon: | n/a |
38 | chr12:21815512-21815562 | AG04449 | skin: | fetal |
39 | chr12:21815512-21815562 | BJ | skin: | n/a |
40 | chr12:21815512-21815562 | HRE | kidney: | n/a |
41 | chr12:21815512-21815562 | LNCaP | prostate: | n/a |
42 | chr12:21815512-21815562 | Hela-S3 | cervix: | n/a |
43 | chr12:21815512-21815562 | HL-60 | blood: | n/a |
44 | chr12:21815512-21815562 | GM06990 | blood: | n/a |
45 | chr12:21815512-21815562 | SK-N-SH_RA | brain: | n/a |
46 | chr12:21815512-21815562 | HCPEpiC | choroid plexus: | n/a |
47 | chr12:21815512-21815562 | HIPEpiC | eye: | n/a |
48 | chr12:21815512-21815562 | HepG2 | liver: | n/a |
49 | chr12:21815512-21815562 | K562 | blood: | n/a |
50 | chr12:21815512-21815562 | NB4 | blood: | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C12orf39-1 | chr12:21815247-21815705 | ENSG00000256615.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
LDHB | TF binding region |
LDHB | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs59805820 | chr12:21815537-21815538 | Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS | TF binding regionCpG islandlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs184665633 | chr12:21815546-21815547 | Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS | TF binding regionCpG islandlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs567317103 | chr12:21815547-21815548 | Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS | TF binding regionCpG islandlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs559298723 | chr12:21815561-21815562 | Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS | TF binding regionCpG islandlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs536571451 | chr12:21815562-21815563 | Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS | TF binding regionCpG islandlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs74184609 | chr12:21815564-21815565 | Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | mRNA abundance |
7 | rs570459497 | chr12:21815565-21815566 | Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs112041439 | chr12:21815577-21815578 | Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs73077300 | chr12:21815580-21815581 | Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs187443974 | chr12:21815602-21815603 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs371583481 | chr12:21815606-21815607 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs79662965 | chr12:21815607-21815608 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs191934168 | chr12:21815609-21815610 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs191383545 | chr12:21815610-21815611 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs78929102 | chr12:21815612-21815613 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | mRNA abundance |
16 | rs555225048 | chr12:21815624-21815625 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs543476910 | chr12:21815643-21815644 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs563928579 | chr12:21815648-21815649 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs76654229 | chr12:21815650-21815651 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | mRNA abundance |
20 | rs376407548 | chr12:21815662-21815663 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs73262354 | chr12:21815663-21815664 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs80042173 | chr12:21815665-21815666 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | mRNA abundance |
23 | rs146857244 | chr12:21815669-21815670 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs200405782 | chr12:21815671-21815672 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs551397853 | chr12:21815672-21815673 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs564831179 | chr12:21815677-21815678 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs192760359 | chr12:21815680-21815681 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs577273892 | chr12:21815705-21815706 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs66978947 | chr12:21815725-21815726 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs114895869 | chr12:21815735-21815736 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs184168131 | chr12:21815764-21815765 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs546765042 | chr12:21815766-21815767 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs562889936 | chr12:21815772-21815773 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs12826014 | chr12:21815800-21815801 | Weak transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs146706252 | chr12:21815801-21815802 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs557745170 | chr12:21815810-21815811 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs12824936 | chr12:21815820-21815821 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs114407226 | chr12:21815835-21815836 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs557206795 | chr12:21815839-21815840 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs72276276 | chr12:21815875-21815876 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574068426 | chr12:21815876-21815877 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs75832204 | chr12:21815881-21815882 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs12824788 | chr12:21815898-21815899 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs139292160 | chr12:21815922-21815923 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545685086 | chr12:21815941-21815942 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564897696 | chr12:21815955-21815956 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12825320 | chr12:21815979-21815980 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs372675065 | chr12:21815988-21815989 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190784007 | chr12:21815996-21815997 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71452236 | chr12:21816004-21816005 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Malignant germ cell tumour | 17285132 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 16397240 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21364760 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22102821 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 22048815 | CNVD |
Malignant peripheral nerve sheath tumor | 19844265 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Heart disease | 21282601 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 17925434 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Gastric cancer | 24379144 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Gastric cancer | 19545448 | CNVD |
Lung cancer | 20031968 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung adenocarcinoma | 19826477 | CNVD |
Lung cancer | 19525976 | CNVD |
Lung cancer | 19826477 | CNVD |
Non-small cell lung cancer | 19451690 | CNVD |
Non-small cell lung cancer | 17504988 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Lung cancer | 19671679 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:21810800-21816400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr12:21815400-21815600 | Flanking Active TSS | Skeletal Muscle Male | skeletal muscle |
3 | chr12:21815400-21815800 | Active TSS | Muscle Satellite Cultured Cells | -- |
4 | chr12:21815400-21815800 | Active TSS | Fetal Muscle Trunk | muscle |
5 | chr12:21815400-21816000 | Bivalent/Poised TSS | Skeletal Muscle Female | skeletal muscle |
6 | chr12:21815400-21816200 | Active TSS | A549 | lung |
7 | chr12:21815600-21815800 | Active TSS | Skeletal Muscle Male | skeletal muscle |
8 | chr12:21815800-21816000 | Flanking Bivalent TSS/Enh | Skeletal Muscle Male | skeletal muscle |
9 | chr12:21816200-21818800 | Weak transcription | A549 | lung |
10 | chr12:21816400-21817000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |